SOFIE

SOFIE

Private
VirginiaHealthcare & Life Scienceshttps://www.sofie.com

Last Round

Private Equity

Jun 4, 2024

Est. Valuation

$540.43M

Total Funding Raised

$34.4M

Company Overview

SOFIE is a healthcare technology company that develops molecular imaging probes and devices to provide radiopharmaceutical products for in vivo research, assisting physicians in identifying tumors responsive to targeted therapies and enhancing personalized healthcare through innovative theranostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Pharma Supply Chain, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

radiopharmaceuticalsradiopharmacy networktheranosticsPET imaging agentscontract manufacturingCDMOradiopharmaceutical CDMOnuclear medicinemolecular diagnosticsPET imagingPylarifyprostate cancer imagingclinical trial supplyradioisotopesradiochemistrycyclotron productionFDGNeuraceqpharma supply chaingovernment contracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SOFIE Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SOFIE Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Private EquityJun 4, 2024
Series CNov 9, 2020
VC RoundJun 13, 2016
Series AOct 15, 2013
SeedDec 8, 2010

Key People

Founding team and executive leadership

Patrick W. Phelps

President, CEO, Board Member

Executive Team

SOFIE Investors

Notable investors and investment history

InvestorRounds
Trilantic North AmericaPrivate Equity
Cycad GroupSeed, Series A
Tata Industries LimitedSeries A
MRM Capital HoldingsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Developing new radiopharmaceutical FAPI-74 for theranostic use.

SOFIE Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SOFIE Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SOFIE's valuation, stock price, and market status.

Firmographic Details

HeadquartersVirginia
Employee Range362
Year Founded2008
Last FundingJun 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.